112 related articles for article (PubMed ID: 19951267)
1. Psychometric properties of a Norwegian version of Multiple Sclerosis Impact Scale (MSIS-29).
Smedal T; Johansen HH; Myhr KM; Strand LI
Acta Neurol Scand; 2010 Oct; 122(4):244-51. PubMed ID: 19951267
[TBL] [Abstract][Full Text] [Related]
2. Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study.
Gray O; McDonnell G; Hawkins S
Mult Scler; 2009 Jan; 15(1):75-80. PubMed ID: 18829636
[TBL] [Abstract][Full Text] [Related]
3. [Validation of selected aspects of psychometry of the Polish version of the Multiple Sclerosis Impact Scale 29 (MSIS-29)].
Jamroz-Wiśniewska A; Papuć E; Bartosik-Psujek H; Belniak E; Mitosek-Szewczyk K; Stelmasiak Z
Neurol Neurochir Pol; 2007; 41(3):215-22. PubMed ID: 17629814
[TBL] [Abstract][Full Text] [Related]
4. Psychometric properties of the Fatigue Severity Scale: Rasch analyses of responses in a Norwegian and a Swedish MS cohort.
Lerdal A; Johansson S; Kottorp A; von Koch L
Mult Scler; 2010 Jun; 16(6):733-41. PubMed ID: 20558503
[TBL] [Abstract][Full Text] [Related]
5. The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure.
McGuigan C; Hutchinson M
J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):266-9. PubMed ID: 14742602
[TBL] [Abstract][Full Text] [Related]
6. Beyond the reach of traditional analyses: using Rasch to evaluate the DASH in people with multiple sclerosis.
Cano SJ; Barrett LE; Zajicek JP; Hobart JC
Mult Scler; 2011 Feb; 17(2):214-22. PubMed ID: 20947530
[TBL] [Abstract][Full Text] [Related]
7. Psychometric properties of the Italian version of the Guy's Neurological Disability Scale.
Pappalardo A; Patti F
Funct Neurol; 2010; 25(4):223-33. PubMed ID: 21388584
[TBL] [Abstract][Full Text] [Related]
8. Comparison of patient-reported outcome measures in multiple sclerosis.
Schäffler N; Schönberg P; Stephan J; Stellmann JP; Gold SM; Heesen C
Acta Neurol Scand; 2013 Aug; 128(2):114-21. PubMed ID: 23398571
[TBL] [Abstract][Full Text] [Related]
9. Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trøndelag County, Norway.
Dahl OP; Stordal E; Lydersen S; Midgard R
Mult Scler; 2009 Dec; 15(12):1495-501. PubMed ID: 19965515
[TBL] [Abstract][Full Text] [Related]
10. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.
Drake AS; Weinstock-Guttman B; Morrow SA; Hojnacki D; Munschauer FE; Benedict RH
Mult Scler; 2010 Feb; 16(2):228-37. PubMed ID: 20028710
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients.
Honarmand K; Feinstein A
Mult Scler; 2009 Dec; 15(12):1518-24. PubMed ID: 19965520
[TBL] [Abstract][Full Text] [Related]
12. Rasch analysis of the Fatigue Severity Scale in multiple sclerosis.
Mills R; Young C; Nicholas R; Pallant J; Tennant A
Mult Scler; 2009 Jan; 15(1):81-7. PubMed ID: 18755824
[TBL] [Abstract][Full Text] [Related]
13. The Multiple Sclerosis Self-Management Scale: revision and psychometric analysis.
Bishop M; Frain MP
Rehabil Psychol; 2011 May; 56(2):150-9. PubMed ID: 21574735
[TBL] [Abstract][Full Text] [Related]
14. Validity of an Internet version of the Multiple Sclerosis Neuropsychological Questionnaire.
Akbar N; Honarmand K; Kou N; Levine B; Rector N; Feinstein A
Mult Scler; 2010 Dec; 16(12):1500-6. PubMed ID: 20813773
[TBL] [Abstract][Full Text] [Related]
15. Confirmation and extension of the validity of the Multiple Sclerosis Walking Scale-12 (MSWS-12).
Motl RW; Snook EM
J Neurol Sci; 2008 May; 268(1-2):69-73. PubMed ID: 18061618
[TBL] [Abstract][Full Text] [Related]
16. Impact of depression and disability on quality of life in Iranian patients with multiple sclerosis.
Ayatollahi P; Nafissi S; Eshraghian MR; Kaviani H; Tarazi A
Mult Scler; 2007 Mar; 13(2):275-7. PubMed ID: 17439899
[TBL] [Abstract][Full Text] [Related]
17. Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use.
van der Linden FA; Kragt JJ; Klein M; van der Ploeg HM; Polman CH; Uitdehaag BM
J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1677-81. PubMed ID: 16291893
[TBL] [Abstract][Full Text] [Related]
18. Validity and reliability of the Finnish version of the Multiple Sclerosis Impact Scale-29.
Rosti-Otajärvi E; Hämäläinen P; Wiksten A; Hakkarainen T; Ruutiainen J
Brain Behav; 2017 Jul; 7(7):e00725. PubMed ID: 28729932
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing the health-related quality of life in Hungarian multiple sclerosis patients.
Füvesi J; Bencsik K; Losonczi E; Fricska-Nagy Z; Mátyás K; Mészáros E; Benedek K; Rajda C; Lencsés G; Vécsei L
J Neurol Sci; 2010 Jun; 293(1-2):59-64. PubMed ID: 20394948
[TBL] [Abstract][Full Text] [Related]
20. Psychometric properties of the TSK-11: a shortened version of the Tampa Scale for Kinesiophobia.
Woby SR; Roach NK; Urmston M; Watson PJ
Pain; 2005 Sep; 117(1-2):137-44. PubMed ID: 16055269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
